Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Evolent Health, Inc.

Get SEC filing alerts via email and in your feed for Evolent Health, Inc.

EVH

Evolent Health, Inc.

About Evolent Health, Inc.

Evolent Health, Inc. provides technology-enabled healthcare solutions focused on value-based care management across specialty areas like oncology, cardiology, and musculoskeletal conditions. Serving health plans, providers, and payers, it offers clinical pathways, provider network development, and administrative services to improve care quality and reduce costs. Its proprietary platforms support data integration, clinical decision-making, and risk-sharing arrangements in the evolving U.S. healthcare delivery landscape.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Evolent Health, Inc.

1
1
Evolent Health, Inc. Evolent Health Reports $496.2 Million Revenue in Q1 2026, Operating Loss Increases

Via official filing (AI summary) | 29 days ago | 0 comments

2
1
Evolent Health, Inc. Evolent Health Reports $1.876 Billion Revenue Decline and $579.4 Million Net Loss for 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Evolent Health, Inc. Evolent Health Reports 22.8% Revenue Decline in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Evolent Health, Inc. Evolent Health Reports 31.3% Revenue Decline in Q2 2025, Net Loss of $51.1 Million

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Evolent Health, Inc. Evolent Health Reports 24.4% Revenue Decline and Increased Net Loss in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Evolent Health, Inc. Evolent Health Reports 21.6% Revenue Growth, Operating Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments